PubRank

Hai Tran

Author PubWeight™ 21.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res 2012 3.48
2 Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer. J Clin Oncol 2005 2.51
3 Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. J Natl Cancer Inst 2005 2.09
4 Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis. Clin Cancer Res 2011 1.49
5 Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effects. Clin Cancer Res 2007 1.22
6 Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen. J Thorac Oncol 2009 1.10
7 Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment. Cancer Res 2008 1.09
8 The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. PLoS One 2013 1.08
9 Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res 2006 1.06
10 Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept. Clin Cancer Res 2011 0.97
11 Genome sequence and functional genomic analysis of the oil-degrading bacterium Oleispira antarctica. Nat Commun 2013 0.91
12 The environment shapes microbial enzymes: five cold-active and salt-resistant carboxylesterases from marine metagenomes. Appl Microbiol Biotechnol 2014 0.83
13 The multiplicity of Staphylococcus aureus in chronic rhinosinusitis: correlating surface biofilm and intracellular residence. Laryngoscope 2012 0.82
14 Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trial. J Thorac Oncol 2013 0.79
15 Genome Sequence of Thalassolituus oleivorans MIL-1 (DSM 14913T). Genome Announc 2013 0.79
16 Prevention of false positive binding during immunofluorescence of Staphylococcus aureus infected tissue biopsies. J Immunol Methods 2012 0.79
17 Reduce readmissions with service-based care management. Prof Case Manag 2014 0.78
18 Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome. J Pediatr Hematol Oncol 2003 0.76
19 Bridging therapy in the perioperative management of patients with drug-eluting stents. Rev Cardiovasc Med 2009 0.75
20 Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma. Mil Med 2006 0.75